Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Non-cash Items (2020 - 2023)

INVO Fertility (IVF) reported Non-cash Items of $82661.0 for Q3 2023, down 90.78% year-over-year from $896139.0 in Q3 2022, and up 16.01% on a QoQ basis from $71251.0 in Q2 2023.

INVO Fertility (IVF) has 4 years of Non-cash Items data on file, last reported at $82661.0 in Q3 2023.

  • Quarterly Non-cash Items fell 90.78% year-over-year to $82661.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $82661.0 (down 90.78% YoY) and the FY2022 annual result came in at $818559.0, up 25.9% from the prior year.
  • Non-cash Items advanced to $82661.0 in Q3 2023 per IVF's latest filing, from $71251.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at $1.1 million in Q1 2023 and bottomed at $17250.0 in Q4 2020.
  • The 4-year median for Non-cash Items is $374256.0 (2021), against an average of $453499.8.
  • The widest annual swing landed in 2022, when Non-cash Items soared 4645.27%; it then plunged 90.94% in 2023.
  • Tracing IVF's Non-cash Items over 4 years: stood at $17250.0 in 2020, then changed by 0.0% to $17250.0 in 2021, then soared by 4645.27% to $818559.0 in 2022, then sank by 89.9% to $82661.0 in 2023.
  • Per Business Quant, the three latest IVF Non-cash Items figures stand at $82661.0 (Q3 2023), $71251.0 (Q2 2023), and $1.1 million (Q1 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 INVO Fertility 5.12 Mn 4.76 Mn 629,345.00

Historic Data

Download Data 🔒
DateValue
Sep 30, 2023 82,661.00
Sep 30, 2023 82,661.00
Jun 30, 2023 71,251.00
Jun 30, 2023 71,251.00
Mar 31, 2023 1.07 Mn
Mar 31, 2023 1.07 Mn
Dec 31, 2022 818,559.00
Dec 31, 2022 818,559.00
Sep 30, 2022 896,139.00
Sep 30, 2022 896,139.00
Jun 30, 2022 786,392.00
Jun 30, 2022 786,392.00
Mar 31, 2022 740,495.00
Mar 31, 2022 740,495.00
Dec 31, 2021 17,250.00
Dec 31, 2021 17,250.00
Sep 30, 2021 333,368.00
Sep 30, 2021 333,368.00
Jun 30, 2021 582,858.00
Jun 30, 2021 582,858.00
Mar 31, 2021 374,256.00
Mar 31, 2021 374,256.00
Dec 31, 2020 17,250.00
Dec 31, 2020 17,250.00
Sep 30, 2020 106,107.00
Sep 30, 2020 106,107.00